Utama › Kanser Kolorektal
Kajian klinikal Kanser Kolorektal sedang mengambil peserta di AS
336 kajian untuk Kanser Kolorektal sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- Houston, TX102 kajian
- New York City, NY77 kajian
- Nashville, TN69 kajian
- Boston, MA63 kajian
- Los Angeles, CA59 kajian
- Arlington, VA52 kajian
- St. Louis, MO50 kajian
- San Antonio, TX46 kajian
- Philadelphia, PA44 kajian
- Grand Rapids, MI40 kajian
- Baldwin Park, CA38 kajian
- Seattle, WA34 kajian
- Tampa, FL33 kajian
- Chicago, IL33 kajian
- Dallas, TX33 kajian
- Aurora, CO32 kajian
- Pittsburgh, PA32 kajian
- Queens, NY31 kajian
- Baltimore, MD31 kajian
- Washington, DC29 kajian
- Atlanta, GA29 kajian
- Rochester, MN29 kajian
- Durham, NC28 kajian
- Portland, OR28 kajian
- Jacksonville, FL27 kajian
- Detroit, MI26 kajian
- Phoenix, AZ25 kajian
- San Diego, CA25 kajian
- Cleveland, OH24 kajian
- Columbus, OH24 kajian
- Ann Arbor, MI23 kajian
- Edison, NJ23 kajian
- Santa Monica, CA23 kajian
- Denver, CO23 kajian
- Madison, WI22 kajian
- Oklahoma City, OK22 kajian
- Salt Lake City, UT21 kajian
- Cincinnati, OH21 kajian
- New Haven, CT20 kajian
- Minneapolis, MN19 kajian
Mengikut negeri
- Alabama12 kajian
- Alaska4 kajian
- Arizona54 kajian
- Arkansas14 kajian
- California137 kajian
- Colorado56 kajian
- Connecticut23 kajian
- Delaware9 kajian
- Florida99 kajian
- Georgia38 kajian
- Hawaii5 kajian
- Idaho6 kajian
- Illinois51 kajian
- Indiana27 kajian
- Iowa15 kajian
- Kansas19 kajian
- Kentucky19 kajian
- Louisiana18 kajian
- Maine4 kajian
- Maryland47 kajian
- Massachusetts63 kajian
- Michigan72 kajian
- Minnesota45 kajian
- Mississippi6 kajian
- Missouri58 kajian
- Montana6 kajian
- Nebraska22 kajian
- Nevada9 kajian
- New Hampshire6 kajian
- New Jersey36 kajian
- New Mexico8 kajian
- New York99 kajian
- North Carolina44 kajian
- North Dakota7 kajian
- Ohio63 kajian
- Oklahoma22 kajian
- Oregon29 kajian
- Pennsylvania69 kajian
- Rhode Island5 kajian
- South Carolina13 kajian
- South Dakota11 kajian
- Tennessee76 kajian
- Texas145 kajian
- Utah36 kajian
- Vermont4 kajian
- Virginia76 kajian
- Washington46 kajian
- West Virginia5 kajian
- Wilayah Columbia17 kajian
- Wisconsin36 kajian
- Wyoming3 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05673148Evaluation for NCI Surgery Branch Clinical Research Protocols
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT00001823Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Mengambil peserta
Umur 65 hingga 82 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05612347A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07525206The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Mengambil pesertaFasa 1/2
Umur 12 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04585750Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
Mengambil pesertaFasa 1
Umur 18 hingga 120 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04847063A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06270706Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06265285Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Mengambil pesertaFasa 2
Umur 18 hingga 72 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT01174121Family Communications After Genetic Testing
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07143487A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06760819Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05176483Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
Mengambil pesertaKajian pemerhatian
Umur 2 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT01915225PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
Mengambil pesertaFasa 2
Umur 18 hingga 120 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05286814177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07189871Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06625775Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT04751435Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06324357PRE-ISPY Phase I/II Oncology Platform Program
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT05868226A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07085091The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06565052The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07285044Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07551596A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT05877599Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.